Suggestions
Share
Journal Information

Statistics

Follow this link to access the full text of the article

Original article
Asciminib for third-line treatment of chronic myeloid leukemia: Cost-effectiveness analysis based on treatment-free remission approach
Asciminib para el tratamiento de la leucemia mieloide crónica en tercera línea: análisis coste-efectividad basado en el enfoque de remisión libre de tratamiento
Antonio Garcia Molina
Corresponding author
antonio.gm.94@gmail.com

Corresponding author at: Pharmacy Unit, Hospital Joan XXIII., Carrer Dr. Mallafré Guasch, 4, 43005 Tarragona, Spain.
Pharmacy Unit, Hospital Joan XXIII, Tarragona, Spain
Read
3914
Times
was read the article
1073
Total PDF
2841
Total HTML
Share statistics
Article information
ISSN: 11306343
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 12 193 87 280
2025 11 313 62 375
2025 10 169 39 208
2025 9 167 50 217
2025 8 145 79 224
2025 7 170 82 252
2025 6 148 47 195
2025 5 184 68 252
2025 4 147 48 195
2025 3 131 40 171
2025 2 112 35 147
2025 1 76 40 116
2024 12 124 45 169
2024 11 71 46 117
2024 10 78 41 119
2024 9 138 54 192
2024 8 109 40 149
2024 7 110 35 145
2024 6 138 61 199
2024 5 98 56 154
2024 4 20 18 38
Show all

Follow this link to access the full text of the article

Idiomas
Farmacia Hospitalaria